DuPont de Nemours, Inc.
DD
Positions held
Your positionsDD isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- DuPont operates in the specialty chemicals industry, which is poised for growth due to increasing demand for sustainable and innovative materials across various sectors.
- Revenue increased by 8% compared to the prior quarter, reaching $1.8 billion.
- The company has a forward P/E ratio of 16.72, indicating potential for earnings growth relative to its current price.
- The specialty chemicals industry faces intense competition, which can pressure margins and profitability.
- Gross margin decreased to 35.1% from 35.8% in the prior quarter.
- DuPont reported a net income of only $143 million in the latest quarter, reflecting ongoing challenges in maintaining profitability.
Fundamentals
| Market cap | $17.89B | Enterprise value | $19.44B | Trailing P/E | 35.61 | Forward P/E | 16.63 |
| PEG | 1.72 | Price / book | 1.30 | Beta | 1.08 | Dividend yield | 1.81% |
| Revenue growth | 4.0% | Earnings growth | 149.6% | Gross margin | 35.1% | Operating margin | 14.2% |
| Profit margin | 0.8% | ROE | 1.8% | ROA | 2.1% | Debt / equity | 0.23 |
| Current ratio | 2.43 | Free cash flow | $1.84B | Analyst recommendation | buy | Mean target | $168.75 |
| 52w high | $157.98 | 52w low | $92.49 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.7B | -$1.9B | $3.1B | $1.7B | — |
| Op margin | 14.3% | 13.8% | 34.8% | 17.8% | 12.4% | — |
| Net income | $143M | $161M | -$126M | -$123M | $59.0M | — |
| Gross margin | 35.1% | 35.8% | 56.4% | 38.9% | 34.6% | — |
| Gross profit | $639M | $602M | -$1.1B | $1.2B | $606M | — |
| Operating income | $260M | $232M | -$652M | $547M | $217M | — |
- Revenue +8% vs prior quarter ($1.8B vs $1.7B).
- Gross margin 35.1% (was 35.8% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $6.8B | $6.7B | $6.6B | $13.0B | — |
| Op margin | 12.6% | 11.1% | 12.4% | 15.5% | — |
| Net income | -$779M | $703M | $423M | $5.9B | — |
| Gross margin | 34.5% | 33.0% | 32.8% | 35.5% | — |
| Gross profit | $2.4B | $2.2B | $2.2B | $4.6B | — |
| Operating income | $860M | $747M | $822M | $2.0B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · SpaceX initiated, Humana upgraded: Wall Street's top analyst calls
2026-10-07 · Citigroup Adjusts Price Target on DuPont de Nemours to $162 From $170
2026-10-06 · Corteva Stock Can Gain 50% After Post-Spin Confusion
2026-10-06 · Nelipak Wins 2026 DuPont™ Tyvek® Sustainable Healthcare Packaging Award for Sustainability In-use
2026-10-06 · DuPont Schedules Third Quarter 2026 Earnings Conference Call
2026-10-05 · UBS Adjusts DuPont de Nemours Price Target to $172 From $178, Maintains Buy Rating
2026-10-05 · DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards
2026-10-02 · Corteva Split Into 2 Companies and Wall Street Sees Big Upside in Both Stocks
2026-10-02 · DuPont Expands Sugar Separation Expertise With New Digital Tool
2026-10-01 · Corteva Stock Isn’t Really Down 80%
Price (daily)
Full chart · RSI · MACD · patterns